Effect of Mineralocorticoid Receptor Blockade in T2DEffect of Mineralocorticoid Receptor Blockade in T2D
Does spironolactone prevent heart disease in patients with type 2 diabetes? Diabetes
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Health | Heart | Heart Disease | Spironolactone